These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 13825372)

  • 1. [The pharmacodynamics of antiparkinsonian substances].
    FROMMEL E; GAILLAND LA; FLEURY C
    Schweiz Arch Neurol Neurochir Psychiatr; 1959; 84():97-109. PubMed ID: 13825372
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of antiparkinson drugs on a phenothiazine-induced catatonic reaction.
    MORPURGO C
    Arch Int Pharmacodyn Ther; 1962 May; 137():84-90. PubMed ID: 14476206
    [No Abstract]   [Full Text] [Related]  

  • 3. Tremorine-induced rage and its antagonism by some antiparkinson drugs.
    FUNCKE AB; BIJLSMA UG; NAUTA WT
    Arch Int Pharmacodyn Ther; 1962 Feb; 135():447-53. PubMed ID: 13895909
    [No Abstract]   [Full Text] [Related]  

  • 4. [EXPERIMENTAL ANTICATALEPTIC ACTION OF SOME ANTIPARKINSONIAN AGENTS].
    BOISSIER JR; SIMON P
    C R Seances Soc Biol Fil; 1964; 158():2025-8. PubMed ID: 14282103
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopaminergic activity of the antimuscarinic antiparkinsonian agents.
    Modell JG; Tandon R; Beresford TP
    J Clin Psychopharmacol; 1989 Oct; 9(5):347-51. PubMed ID: 2551932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiparkinsonian drug abuse: eight case reports.
    Rubinstein JS
    Hosp Community Psychiatry; 1979 Jan; 30(1):34-7. PubMed ID: 758251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USES AND ABUSES OF ANTIPARKINSONIAN MEDICATION.
    JEAN A; DONALD MW; BAN TA
    Am J Psychiatry; 1964 Feb; 120():801-3. PubMed ID: 14115476
    [No Abstract]   [Full Text] [Related]  

  • 8. [NEW ANTIPARKINSONIAN DRUGS].
    LEREBOULLET J
    Rev Prat; 1964 Dec; 14():SUPPL:178-83. PubMed ID: 14243585
    [No Abstract]   [Full Text] [Related]  

  • 9. INTERCHANGEABLITY OF ANTIPARKINSONIAN MEDICATION.
    STJEAN A; DONALD M; BAN TA
    Am J Psychiatry; 1964 Jun; 120():1189-90. PubMed ID: 14154754
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of anticholinergic antiparkinsonian drugs on binding of muscarinic receptor subtypes in rat brain.
    Katayama S; Ishizaki F; Yamamura Y; Khoriyama T; Kito S
    Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):261-70. PubMed ID: 2236897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Iontophoretic study of the central anticholinergic properties of BRL 1288.
    Clarke G; Davies J; Straughan DW
    Br J Pharmacol; 1972 Feb; 44(2):344P-345P. PubMed ID: 4668612
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiparkinsonian drugs (author's transl)].
    Ando K
    No To Shinkei; 1980 Aug; 32(8):743-53. PubMed ID: 7008813
    [No Abstract]   [Full Text] [Related]  

  • 13. Postnatal development of benztropine-induced locomotor stimulation: evidence for an anticholinergic mechanism of action.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):313-20. PubMed ID: 4734004
    [No Abstract]   [Full Text] [Related]  

  • 14. Electroretinographic changes in patients with parkinsonism treated with various classes of antiparkinsonian drugs.
    Filipová M; Balík J; Filip V; Rodný J; Krejcová H
    Act Nerv Super (Praha); 1979 Oct; 21(3):136-8. PubMed ID: 517077
    [No Abstract]   [Full Text] [Related]  

  • 15. [ANTIPARKINSON DRUGS].
    CERRI O; VALCURONE G
    Boll Chim Farm; 1965 Jan; 104():7-22. PubMed ID: 14300054
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological study of piroheptine, a new antiparkinson drug. II. Anticholinergic, antihistaminic, and psychopharmacological actions and toxicity.
    Hitomi M; Watanabe N; Kumadaki N; Kumada S
    Arzneimittelforschung; 1972 Jun; 22(6):961-6. PubMed ID: 4403219
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of amphetamine induced stereotyped behaviour as a model for the experimental evaluation of antiparkinson agents.
    Costall B; Naylor RJ; Wright T
    Arzneimittelforschung; 1972 Jul; 22(7):1178-83. PubMed ID: 4404343
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on antiparkinsonian agents.
    Weiner M
    Geriatrics; 1982 Sep; 37(9):81-4, 89-91. PubMed ID: 6125455
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of piroheptine, a new antiparkinson drug, on dopamine uptake into synaptosomes from corpus striatum of rat brain.
    Ohashi T; Akita H; Tamura T; Noda K; Honda F
    Arzneimittelforschung; 1972 Jun; 22(6):966-72. PubMed ID: 5068358
    [No Abstract]   [Full Text] [Related]  

  • 20. Tardive dyskinesia and anticholinergic drugs.
    Gardos G; Cole JO
    Am J Psychiatry; 1983 Feb; 140(2):200-2. PubMed ID: 6129809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.